François Lamoureux

3PUBLICATIONS
39CO-AUTHORS
Predictive and prognostic markersSocial epidemiologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Oct 20, 2026
Dysregulated AKT signaling reprograms osteosarcoma to drive selective reliance on EP300.

|Feb 24, 2026
EZH2 is a key prognostic marker and therapeutic target in aggressive and proliferative hepatoblastoma.

Fatma Zohra Khoubai, Alexia Calovoulos, Hélène Guillorit

|Feb 05, 2026
Activating GCN2 and subsequently the Unfolded Protein Response with the small oral molecule NXP800 delays tumor growth in osteosarcoma.

Emma Racineau, Morgane Lallier, Anaïs Postec

Pageof 1

Frequent Collaborators

1 joint publications

Anaïs Postec

1 joint publications

Fatma Zohra Khoubai

1 joint publications

Jean-William Dupuy

1 joint publications

Montse Domingo-Sàbat